- Home
- OCUL vs BGM Comparison
OCUL vs BGM Comparison
Compare OCUL & BGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCUL
- BGM
- Stock Information
- Founded
- OCUL 2006
- BGM 2019
- Country
- OCUL United States
- BGM China
- Employees
- OCUL N/A
- BGM N/A
- Industry
- OCUL Biotechnology: Pharmaceutical Preparations
- BGM
- Sector
- OCUL Health Care
- BGM
- Exchange
- OCUL Nasdaq
- BGM NYSE
- Market Cap
- OCUL 957.3M
- BGM 1.0B
- IPO Year
- OCUL 2014
- BGM 2021
- Fundamental
- Price
- OCUL $7.31
- BGM $11.00
- Analyst Decision
- OCUL Strong Buy
- BGM
- Analyst Count
- OCUL 10
- BGM 0
- Target Price
- OCUL $16.22
- BGM N/A
- AVG Volume (30 Days)
- OCUL 1.9M
- BGM 38.0K
- Earning Date
- OCUL 05-06-2025
- BGM 04-29-2025
- Dividend Yield
- OCUL N/A
- BGM N/A
- EPS Growth
- OCUL N/A
- BGM N/A
- EPS
- OCUL N/A
- BGM N/A
- Revenue
- OCUL $63,723,000.00
- BGM $25,097,951.00
- Revenue This Year
- OCUL $13.32
- BGM N/A
- Revenue Next Year
- OCUL $13.13
- BGM N/A
- P/E Ratio
- OCUL N/A
- BGM N/A
- Revenue Growth
- OCUL 9.03
- BGM N/A
- 52 Week Low
- OCUL $4.06
- BGM $2.70
- 52 Week High
- OCUL $11.78
- BGM $14.78
- Technical
- Relative Strength Index (RSI)
- OCUL 51.39
- BGM 54.14
- Support Level
- OCUL $6.94
- BGM $9.35
- Resistance Level
- OCUL $7.83
- BGM $11.84
- Average True Range (ATR)
- OCUL 0.72
- BGM 0.71
- MACD
- OCUL 0.07
- BGM -0.01
- Stochastic Oscillator
- OCUL 74.57
- BGM 66.43
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.